Diaphragm pacing (DP) is a useful and cost-effective alternative to mechanical ventilation in patients with ventilator-dependent spinal cord injury and central hypoventilation syndrome. Patients with spinal cord injuries should be carefully screened to assess the integrity of their phrenic nerves. In eligible patients, diaphragm pacing improves mobility, speech, olfaction, and quality of life. Another, albeit uncommon, application of diaphragm pacing is to treat patients who have intractable hiccups.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (External Diaphragm Pacemaker and Internal Diaphragm Pacemaker), Application (Spinal Cord Injuries (SCI)), (Amyotrophic Lateral Sclerosis (ALS)), Chronic Pain, Parkinson’s Disease, Urine Incontinence, Epilepsy) – Industry Trends and Forecast to 2032
.
The Global Diaphragm Pacing Device Market size was valued at USD 4.68 USD Million in 2024.
The Global Diaphragm Pacing Device Market is projected to grow at a CAGR of 5.4% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
